This suggests that carnitine biosynthesis may play a functional role in how GLP-1 receptor agonists produce their weight loss effects, not just in how the body handles the resulting caloric deficit
list price, it would cost Americans $3.03 trillion across a lifetime
Tirzepatide Once Weekly for the Treatment of Obesity
Dosing errors have also occurred with compounded semaglutide, which many companies offer as an alternative to the GLP-1 medications Ozempic or Wegovy (these brand-name drugs are made by Novo Nordisk)
Clinical trials show gastrointestinal side effects occur in approximately 25-30% of patients, with diarrhea being one of the most commonly reported GI symptoms alongside nausea and constipation
Primary risks include additive cardiovascular effects (increased heart rate and blood pressure), intensified gastrointestinal symptoms (nausea, vomiting, diarrhea), and potential for serious adverse events including pancreatitis and acute kidney injury requiring close monitoring